However, nowadays many drugs have been tried in the treatment of NASH and one of the most frequently used therapeutic drugs is insulin-sensitizing drug, most of which are acting on peroxisome proliferators-activated receptor gamma (PPARγ). The gene discussed is PPARG; the disease is metabolic dysfunction-associated steatohepatitis.